RMD
ResMed Inc
NYSE: RMD · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$211.93
-2.40% today
Updated 2026-04-29
Market cap
$30.87B
P/E ratio
20.96
P/S ratio
5.72x
EPS (TTM)
$10.11
Dividend yield
1.04%
52W range
$212 – $292
Volume
1.0M
ResMed Inc (RMD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
-23.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.4%
Last 4 reports
Positive reaction rate
25%
1 of 4 quarters
Largest single-day move
-2.7%
2026-01-22
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-23 | $0.00 | -100.0% | $222.04 | $219.85 | -1.0% |
| 2026-01-22 | $2.81 | +3.3% | $259.28 | $252.38 | -2.7% |
| 2025-10-23 | $2.55 | +1.6% | $266.48 | $259.49 | -2.6% |
| 2025-07-31 | $2.55 | +2.8% | $277.44 | $279.20 | +0.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $2.78 | $0.00 | -100.0% | — | — |
| 2025-12-31 | $2.72 | $2.81 | +3.3% | $1.42B | +11.0% |
| 2025-09-30 | $2.51 | $2.55 | +1.6% | $1.34B | +9.1% |
| 2025-06-30 | $2.48 | $2.55 | +2.8% | $1.35B | +10.2% |
| 2025-03-31 | $2.36 | $2.37 | +0.4% | $1.29B | +7.9% |
| 2024-12-31 | $2.31 | $2.43 | +5.2% | $1.28B | +10.3% |
| 2024-09-30 | $2.04 | $2.20 | +7.8% | $1.22B | +11.1% |
| 2024-06-30 | $2.07 | $2.08 | +0.5% | $1.22B | — |
| 2024-03-31 | $1.91 | $2.13 | +11.5% | $1.20B | — |
| 2023-12-31 | $1.80 | $1.88 | +4.4% | $1.16B | — |
| 2023-09-30 | $1.62 | $1.64 | +1.2% | $1.10B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $11.12 | $5.7B | +10.6% | 10 | high |
| 2027 (E) | $12.28 | $6.1B | +7.4% | 10 | high |
| 2028 (E) | $13.50 | $6.6B | +7.3% | 10 | medium |
| 2029 (E) | $14.75 | $7.0B | +7.0% | 10 | medium |
| 2030 (E) | $16.10 | $7.5B | +6.8% | 10 | medium |
Frequently asked questions
Has ResMed Inc beaten earnings estimates?
ResMed Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of -23.1% over the last 4 quarters.
How does RMD stock react to earnings?
RMD stock has moved an average of -1.4% in the trading day following earnings over its last 4 reports, with positive reactions in 25% of those quarters.
What is the expected EPS for RMD in 2026?
Analysts expect ResMed Inc to report EPS of $11.12 for fiscal year 2026, on revenue of $5.7B, based on estimates from 10 analysts.